Design, Synthesis and Evaluation Donepezil-Based Dual BuChE/FAAH Inhibitors for Alzheimer’s Disease Therapy
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.6c01848 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Xiaodan Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui Medical University, Hefei230032, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Donepezil, Cholinesterase Inhibitors, Butyrylcholinesterase. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Open Project of Anhui Province Key Laboratory of Occupational Health, Natural Science Foundation of Anhui Province.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is multifactorial, prompting multi-target therapy. A series of donepezil-based derivatives were designed, synthesized, and evaluated as dual inhibitors of human butyrylcholinesterase (hBuChE) and fatty acid amide hydrolase (hFAAH). Among them, lead G15 displayed potent and balanced inhibition with IC50 values of 2.44 μM and 0.17 μM, respectively, and favorable selectivity over carboxylesterases CES1/2 (SI 14.4 and 8.4). G15 not only acted as a time-dependent, mixed-type hFAAH inhibitor and a pseudo-irreversible hBuChE inhibitor, but also exhibited good drug-like properties, including high BBB permeability and oral bioavailability (108%). Moreover, G15 chelated Zn2+, protected PC12 cells from oxidative stress, and promoted microglial M1 → M2 polarization. In an Aβ1−42-induced mouse model, G15 significantly reversed cognitive deficits, outperforming donepezil. Therefore, G15 is poised for further development as a promising multi-target candidate for AD therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Anhui Medical University, Hefei230032, China.
- Kang Chiao School of Xinzhan Zone Hefei City, Hefei230012, China.
- Jiaxing Maternity and Child Health Care Hospital, Affiliated Women and Children Hospital, Jiaxing University, Jiaxing, Zhejiang314000, China.
ORCID-Profile: Wenjian Tang
Förderung
- Open Project of Anhui Province Key Laboratory of Occupational Health
- Natural Science Foundation of Anhui Province
Zitieren
APA
Liu, X., Wu, Y., Ding, Y., Hu, S., Hou, H., Zong, Y., Zhang, Z., & Tang, W. (2026). Design, Synthesis and Evaluation Donepezil-Based Dual BuChE/FAAH Inhibitors for Alzheimer’s Disease Therapy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01848
Vancouver
Liu X, Wu Y, Ding Y, Hu S, Hou H, Zong Y, et al. Design, Synthesis and Evaluation Donepezil-Based Dual BuChE/FAAH Inhibitors for Alzheimer’s Disease Therapy. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01848
BibTeX
@article{Liu2026,
author = {Liu, Xiaodan and Wu, Yinxin and Ding, Yulu and Hu, Shilin and Hou, Hui and Zong, Yicheng and Zhang, Ziwen and Tang, Wenjian},
title = {Design, Synthesis and Evaluation Donepezil-Based Dual BuChE/FAAH Inhibitors for Alzheimer’s Disease Therapy},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c01848}
}
EUVIMED